Sangers Sequencing Service Market by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others) and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics) - Global Opportunity Analysis and Industry Forecast, 2013-2025
Sanger’s sequencing method is based on the principle of detecting labelled chain-terminating nucleotides, which are incorporated by a DNA polymerase during the replication of a template. This method of sequencing is also known as chain termination or dideoxy sequencing. The global Sanger’s sequencing service market was valued at $192 million in 2013, and is estimated to reach at $1,085 million by 2025, registering a CAGR of 14.2% from 2018 to 2025.
As Sanger’s sequencing is known as the gold standard of sequencing technologies, as it offers long read capability and a high-degree of accuracy. Sanger’s sequencing services are routinely offered by sequencing companies to different end users such as academic institutes and hospitals for sequence analysis.
Advantages associated with Sanger’s sequencing, technological advancements in sequencing procedures, and surge in application of Sanger’s sequencing are the key factors that boost market growth. Furthermore, increase in genome mapping programs; rise in awareness pertaining to DNA sequencing; and increase in investment in research, development, & innovation have bolstered the market growth.
However, dearth of skilled professionals and standardization concerns in sequencing procedures impede the market growth. Conversely, the use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to offer lucrative opportunities for market players in the near future.
The Sanger’s sequencing service market is segmented based on application, end user, and region. By application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. Deepening on end user, it is fragmented into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, the market is classified into the following regions, namely, the United States, EU, Japan, China, India, Southeast Asia, and rest of the world (ROW).
KEY BENEFITS
By Application
As Sanger’s sequencing is known as the gold standard of sequencing technologies, as it offers long read capability and a high-degree of accuracy. Sanger’s sequencing services are routinely offered by sequencing companies to different end users such as academic institutes and hospitals for sequence analysis.
Advantages associated with Sanger’s sequencing, technological advancements in sequencing procedures, and surge in application of Sanger’s sequencing are the key factors that boost market growth. Furthermore, increase in genome mapping programs; rise in awareness pertaining to DNA sequencing; and increase in investment in research, development, & innovation have bolstered the market growth.
However, dearth of skilled professionals and standardization concerns in sequencing procedures impede the market growth. Conversely, the use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to offer lucrative opportunities for market players in the near future.
The Sanger’s sequencing service market is segmented based on application, end user, and region. By application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. Deepening on end user, it is fragmented into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, the market is classified into the following regions, namely, the United States, EU, Japan, China, India, Southeast Asia, and rest of the world (ROW).
KEY BENEFITS
- This report entails a detailed quantitative analysis of the current market trends and future estimations from 2013 to 2025 to identify the prevailing opportunities.
- Sanger’s sequencing service market size and market estimations are based on comprehensive analysis of the applications, end users, and developments in the industry.
- In-depth analysis based on region assists to understand the regional market and the strategic business planning.
- The development strategies adopted by key market players are enlisted to understand the competitive scenario of the market
By Application
- Diagnostics
- Biomarkers & Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Others
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Rest of the World (ROW)
- Source BioScience
- GenScript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- LGC Science Group Limited
- Fasteris SA
- CeMIA SA
- Quintara Biosciences
- GenHunter Corporation
- Eurofins Scientific SE
- GENEWIZ
- Nucleics
- SciGenom Labs Pvt. Limited
- Microsynth AG. Inc.
- Laragen, Inc.
- StarSEQ GmbH
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market scope and definition
3.2. Competitive environment analysis
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2016
3.4. Patent analysis, 2010-2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Technological advancements in Sangers sequencing
3.5.1.2. Surge in applications of Sangers sequencing
3.5.1.3. Increase in genome mapping programs
3.5.2. Restraints
3.5.2.1. Lack of skilled professionals
3.5.2.2. Standardization concerns over sequencing-based diagnostics
3.5.3. Opportunities
3.5.3.1. Cloud computing serves as a potential data management service
3.5.3.2. Lucrative opportunities in the emerging markets
CHAPTER 4: GLOBAL AND REGIONAL SANGERS SEQUENCING SERVICE MARKET SHARE ANALYSIS
4.1. Global Sangers sequencing services market share analysis, 2017
4.2. U.S. Sangers sequencing services market share analysis, 2017
4.3. Europe Sangers sequencing services market share analysis, 2017
4.4. Japan Sangers sequencing services market share analysis, 2017
4.5. China Sangers sequencing services market share analysis, 2017
4.6. India Sangers sequencing services market share analysis, 2017
4.7. South-East Asia Sangers sequencing services market share analysis, 2017
4.8. Rest of the world Sangers sequencing services market share analysis, 2017
CHAPTER 5: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diagnostics
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region
5.3. Biomarkers & cancer
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region
5.4. Reproductive health
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region
5.5. Personalized medicine
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region
5.6. Forensics
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region
CHAPTER 6: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Academic & government research institutes
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by region
6.3. Pharmaceutical companies
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by region
6.4. Biotechnology companies
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by region
6.5. Hospitals & clinics
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by region
CHAPTER 7: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. U.S.
7.2.1. Key market trends
7.2.2. U.S. market size and forecast
7.2.2.1. U.S. Sangers sequencing service market, by application
7.2.2.2. U.S. Sangers sequencing service market, by end user
7.3. Europe
7.3.1. Key market trends
7.3.2. Europe market size and forecast
7.3.2.1. Europe Sangers sequencing service market, by application
7.3.2.2. Europe Sangers sequencing service market, by end user
7.4. Japan
7.4.1. Key market trends
7.4.2. Japan market size and forecast
7.4.2.1. Japan Sangers sequencing service market, by application
7.4.2.2. Japan Sangers sequencing service market, by end user
7.5. China
7.5.1. Key market trends
7.5.2. China market size and forecast
7.5.2.1. China Sangers sequencing service market, by application
7.5.2.2. China Sangers sequencing service market, by end user
7.6. India
7.6.1. Key market trends
7.6.2. India market size and forecast
7.6.2.1. India Sangers sequencing service market, by application
7.6.2.2. India Sangers sequencing service market, by end user
7.7. Southeast Asia
7.7.1. Key market trends
7.7.2. Southeast Asia market size and forecast
7.7.2.1. Southeast Asia Sangers sequencing service market, by application
7.7.2.2. Southeast Asia Sangers sequencing service market, by end user
7.8. Rest of the world
7.8.1. Key market trends
7.8.2. Rest of the world market size and forecast
7.8.2.1. Rest of the world Sangers sequencing service market, by application
7.8.2.2. Rest of the world Sangers sequencing service market, by end user
CHAPTER 8: COMPANY PROFILES
8.1. CeMIA SA
8.1.1. Company Profile
8.1.2. Main business/business overview
8.1.3. Products, services, and solutions
8.1.4. CeMIA Revenue (Million USD)
8.2. Fasteris SA
8.2.1. Company Profile
8.2.2. Main business/business overview
8.2.3. Products, Services, and Solutions
8.2.4. Fasteris revenue (million USD)
8.3. GENEWIZ, Inc.
8.3.1. Company Profile
8.3.2. Main business/business overview
8.3.3. Products, services, and solutions
8.3.4. GENEWIZ Revenue (Million USD)
8.3.5. Recent developments
8.4. GenHunter Corporation
8.4.1. Company Profile
8.4.2. Main business/business overview
8.4.3. Products, Services, and Solutions
8.4.4. GenHunter revenue (million USD)
8.5. Genscript Biotech Corporation
8.5.1. Company Profile
8.5.2. Main Business/Business Overview
8.5.3. Products, Services, and Solutions
8.5.4. GenScript revenue (million USD)
8.6. LGC Science Group Holdings Limited
8.6.1. Company Profile
8.6.2. Main Business/Business Overview
8.6.3. Products, Services, and Solutions
8.6.4. LGC revenue (million USD)
8.6.5. Recent developments
8.7. Microsynth AG
8.7.1. Company Profile
8.7.2. Main business/business overview
8.7.3. Products, Services, and Solutions
8.7.4. Microsynth revenue (million USD)
8.8. Nucleics Pty. Ltd.
8.8.1. Company Profile
8.8.2. Main Business/Business Overview
8.8.3. Products, Services, and Solutions
8.8.4. Nucleics revenue (million USD)
8.9. Quintara Biosciences
8.9.1. Company Profile
8.9.2. Main Business/Business Overview
8.9.3. Products, Services, and Solutions
8.9.4. Quintara revenue (million USD)
8.9.5. Recent Developments
8.10. SciGenom Labs Pvt. Ltd.
8.10.1. Company Profile
8.10.2. Main business/business overview
8.10.3. Products, Services, and Solutions
8.10.4. SciGenom Labs revenue (million USD)
8.11. Source BioScience Plc
8.11.1. Company Profile
8.11.2. Main business/business overview
8.11.3. Products, services, and solutions
8.11.4. Source BioScience revenue (million USD)
8.12. Thermo Fisher Scientific Inc.
8.12.1. Company Profile
8.12.2. Main business/business overview
8.12.3. Products, services, and solutions
8.12.4. Thermo Fisher revenue (million USD)
8.12.5. Recent developments
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market scope and definition
3.2. Competitive environment analysis
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2016
3.4. Patent analysis, 2010-2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Technological advancements in Sangers sequencing
3.5.1.2. Surge in applications of Sangers sequencing
3.5.1.3. Increase in genome mapping programs
3.5.2. Restraints
3.5.2.1. Lack of skilled professionals
3.5.2.2. Standardization concerns over sequencing-based diagnostics
3.5.3. Opportunities
3.5.3.1. Cloud computing serves as a potential data management service
3.5.3.2. Lucrative opportunities in the emerging markets
CHAPTER 4: GLOBAL AND REGIONAL SANGERS SEQUENCING SERVICE MARKET SHARE ANALYSIS
4.1. Global Sangers sequencing services market share analysis, 2017
4.2. U.S. Sangers sequencing services market share analysis, 2017
4.3. Europe Sangers sequencing services market share analysis, 2017
4.4. Japan Sangers sequencing services market share analysis, 2017
4.5. China Sangers sequencing services market share analysis, 2017
4.6. India Sangers sequencing services market share analysis, 2017
4.7. South-East Asia Sangers sequencing services market share analysis, 2017
4.8. Rest of the world Sangers sequencing services market share analysis, 2017
CHAPTER 5: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diagnostics
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region
5.3. Biomarkers & cancer
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region
5.4. Reproductive health
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region
5.5. Personalized medicine
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region
5.6. Forensics
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region
CHAPTER 6: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Academic & government research institutes
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by region
6.3. Pharmaceutical companies
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by region
6.4. Biotechnology companies
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by region
6.5. Hospitals & clinics
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by region
CHAPTER 7: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. U.S.
7.2.1. Key market trends
7.2.2. U.S. market size and forecast
7.2.2.1. U.S. Sangers sequencing service market, by application
7.2.2.2. U.S. Sangers sequencing service market, by end user
7.3. Europe
7.3.1. Key market trends
7.3.2. Europe market size and forecast
7.3.2.1. Europe Sangers sequencing service market, by application
7.3.2.2. Europe Sangers sequencing service market, by end user
7.4. Japan
7.4.1. Key market trends
7.4.2. Japan market size and forecast
7.4.2.1. Japan Sangers sequencing service market, by application
7.4.2.2. Japan Sangers sequencing service market, by end user
7.5. China
7.5.1. Key market trends
7.5.2. China market size and forecast
7.5.2.1. China Sangers sequencing service market, by application
7.5.2.2. China Sangers sequencing service market, by end user
7.6. India
7.6.1. Key market trends
7.6.2. India market size and forecast
7.6.2.1. India Sangers sequencing service market, by application
7.6.2.2. India Sangers sequencing service market, by end user
7.7. Southeast Asia
7.7.1. Key market trends
7.7.2. Southeast Asia market size and forecast
7.7.2.1. Southeast Asia Sangers sequencing service market, by application
7.7.2.2. Southeast Asia Sangers sequencing service market, by end user
7.8. Rest of the world
7.8.1. Key market trends
7.8.2. Rest of the world market size and forecast
7.8.2.1. Rest of the world Sangers sequencing service market, by application
7.8.2.2. Rest of the world Sangers sequencing service market, by end user
CHAPTER 8: COMPANY PROFILES
8.1. CeMIA SA
8.1.1. Company Profile
8.1.2. Main business/business overview
8.1.3. Products, services, and solutions
8.1.4. CeMIA Revenue (Million USD)
8.2. Fasteris SA
8.2.1. Company Profile
8.2.2. Main business/business overview
8.2.3. Products, Services, and Solutions
8.2.4. Fasteris revenue (million USD)
8.3. GENEWIZ, Inc.
8.3.1. Company Profile
8.3.2. Main business/business overview
8.3.3. Products, services, and solutions
8.3.4. GENEWIZ Revenue (Million USD)
8.3.5. Recent developments
8.4. GenHunter Corporation
8.4.1. Company Profile
8.4.2. Main business/business overview
8.4.3. Products, Services, and Solutions
8.4.4. GenHunter revenue (million USD)
8.5. Genscript Biotech Corporation
8.5.1. Company Profile
8.5.2. Main Business/Business Overview
8.5.3. Products, Services, and Solutions
8.5.4. GenScript revenue (million USD)
8.6. LGC Science Group Holdings Limited
8.6.1. Company Profile
8.6.2. Main Business/Business Overview
8.6.3. Products, Services, and Solutions
8.6.4. LGC revenue (million USD)
8.6.5. Recent developments
8.7. Microsynth AG
8.7.1. Company Profile
8.7.2. Main business/business overview
8.7.3. Products, Services, and Solutions
8.7.4. Microsynth revenue (million USD)
8.8. Nucleics Pty. Ltd.
8.8.1. Company Profile
8.8.2. Main Business/Business Overview
8.8.3. Products, Services, and Solutions
8.8.4. Nucleics revenue (million USD)
8.9. Quintara Biosciences
8.9.1. Company Profile
8.9.2. Main Business/Business Overview
8.9.3. Products, Services, and Solutions
8.9.4. Quintara revenue (million USD)
8.9.5. Recent Developments
8.10. SciGenom Labs Pvt. Ltd.
8.10.1. Company Profile
8.10.2. Main business/business overview
8.10.3. Products, Services, and Solutions
8.10.4. SciGenom Labs revenue (million USD)
8.11. Source BioScience Plc
8.11.1. Company Profile
8.11.2. Main business/business overview
8.11.3. Products, services, and solutions
8.11.4. Source BioScience revenue (million USD)
8.12. Thermo Fisher Scientific Inc.
8.12.1. Company Profile
8.12.2. Main business/business overview
8.12.3. Products, services, and solutions
8.12.4. Thermo Fisher revenue (million USD)
8.12.5. Recent developments
LIST OF TABLES
TABLE 01. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 02. SANGERS SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, BY REGION, 2013-2025 ($MILLION)
TABLE 03. SANGERS SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, BY REGION, 2013-2025 ($MILLION)
TABLE 04. SANGERS SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2013-2025 ($MILLION)
TABLE 05. SANGERS SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2013-2025 ($MILLION)
TABLE 06. SANGERS SEQUENCING SERVICE MARKET FOR FORENSICS, BY REGION, 2013-2025 ($MILLION)
TABLE 07. SANGERS SEQUENCING SERVICE MARKET FOR OTHERS, BY REGION, 2013-2025 ($MILLION)
TABLE 08. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 09. SANGERS SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2025 ($MILLION)
TABLE 10. SANGERS SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 11. SANGERS SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 12. SANGERS SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2013-2025 ($MILLION)
TABLE 13. SANGERS SEQUENCING SERVICE MARKET, BY REGION, 2013-2025 ($MILLION)
TABLE 14. U.S. SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 15. U.S. SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 16. Europe SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 17. Europe SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 18. JAPAN SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 19. JAPAN SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 20. CHINA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 21. CHINA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 22. INDIA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 23. INDIA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 24. SOUTHEAST ASIA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 25. SOUTHEAST ASIA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 26. REST OF THE WORLD SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 27. REST OF THE WORLD SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 28. CEMIA: COMPANY SNAPSHOT
TABLE 29. FASTERIS: COMPANY SNAPSHOT
TABLE 30. GENEWIZ: COMPANY SNAPSHOT
TABLE 31. GENHUNTER: COMPANY SNAPSHOT
TABLE 32. GENSCRIPT: COMPANY SNAPSHOT
TABLE 33. LGC: COMPANY SNAPSHOT
TABLE 34. MICROSYNTH: COMPANY SNAPSHOT
TABLE 35. NUCLEICS: COMPANY SNAPSHOT
TABLE 36. QUINTARA: COMPANY SNAPSHOT
TABLE 37. SCIGENOM LABS: COMPANY SNAPSHOT
TABLE 38. SOURCE BIOSCIENCE: COMPANY SNAPSHOT
TABLE 39. THERMO FISHER: COMPANY SNAPSHOT
TABLE 01. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 02. SANGERS SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, BY REGION, 2013-2025 ($MILLION)
TABLE 03. SANGERS SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, BY REGION, 2013-2025 ($MILLION)
TABLE 04. SANGERS SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2013-2025 ($MILLION)
TABLE 05. SANGERS SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2013-2025 ($MILLION)
TABLE 06. SANGERS SEQUENCING SERVICE MARKET FOR FORENSICS, BY REGION, 2013-2025 ($MILLION)
TABLE 07. SANGERS SEQUENCING SERVICE MARKET FOR OTHERS, BY REGION, 2013-2025 ($MILLION)
TABLE 08. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 09. SANGERS SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2025 ($MILLION)
TABLE 10. SANGERS SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 11. SANGERS SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 12. SANGERS SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2013-2025 ($MILLION)
TABLE 13. SANGERS SEQUENCING SERVICE MARKET, BY REGION, 2013-2025 ($MILLION)
TABLE 14. U.S. SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 15. U.S. SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 16. Europe SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 17. Europe SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 18. JAPAN SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 19. JAPAN SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 20. CHINA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 21. CHINA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 22. INDIA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 23. INDIA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 24. SOUTHEAST ASIA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 25. SOUTHEAST ASIA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 26. REST OF THE WORLD SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 27. REST OF THE WORLD SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 28. CEMIA: COMPANY SNAPSHOT
TABLE 29. FASTERIS: COMPANY SNAPSHOT
TABLE 30. GENEWIZ: COMPANY SNAPSHOT
TABLE 31. GENHUNTER: COMPANY SNAPSHOT
TABLE 32. GENSCRIPT: COMPANY SNAPSHOT
TABLE 33. LGC: COMPANY SNAPSHOT
TABLE 34. MICROSYNTH: COMPANY SNAPSHOT
TABLE 35. NUCLEICS: COMPANY SNAPSHOT
TABLE 36. QUINTARA: COMPANY SNAPSHOT
TABLE 37. SCIGENOM LABS: COMPANY SNAPSHOT
TABLE 38. SOURCE BIOSCIENCE: COMPANY SNAPSHOT
TABLE 39. THERMO FISHER: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 01. GLOBAL SANGERS SEQUENCING SERVICE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2017
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2017 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2017
FIGURE 06. TOP PLAYER POSITIONING, 2016
FIGURE 07. PATENT ANALYSIS, BY YEAR
FIGURE 08. PATENT ANALYSIS, BY REGION
FIGURE 09. GLOBAL SANGERS SEQUENCING SERVICE MARKET: IMPACT ANALYSES
FIGURE 10. GLOBAL SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 11. U.S. SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 12. Europe SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 13. JAPAN SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 14. CHINA SANGERS SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2017
FIGURE 15. INDIA SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 16. SOUTH-EAST ASIA SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 17. REST OF THE WORLD SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 18. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION
FIGURE 19. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, 2013 AND 2025 ($MILLION)
FIGURE 20. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, 2013 AND 2025 ($MILLION)
FIGURE 21. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, 2013 AND 2025 ($MILLION)
FIGURE 22. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, 2013 AND 2025 ($MILLION)
FIGURE 23. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR FORENSICS, 2013 AND 2025 ($MILLION)
FIGURE 24. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR OTHERS, 2013 AND 2025 ($MILLION)
FIGURE 25. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2013 AND 2025 ($MILLION)
FIGURE 26. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 27. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 28. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, 2013 AND 2025 ($MILLION)
FIGURE 29. GENSCRIPT: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 31. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)
FIGURE 32. LGC: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. SOURCE BIOSCIENCE: NET SALES, 2013-2015 ($MILLION)
FIGURE 34. SOURCE BIOSCIENCE: REVENUE SHARE BY DIVISION, 2015 ($MILLION)
FIGURE 35. THERMO FISHER: NET SALES, 2015-2017 ($MILLION)
FIGURE 36. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 37. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)
FIGURE 01. GLOBAL SANGERS SEQUENCING SERVICE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2017
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2017 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2017
FIGURE 06. TOP PLAYER POSITIONING, 2016
FIGURE 07. PATENT ANALYSIS, BY YEAR
FIGURE 08. PATENT ANALYSIS, BY REGION
FIGURE 09. GLOBAL SANGERS SEQUENCING SERVICE MARKET: IMPACT ANALYSES
FIGURE 10. GLOBAL SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 11. U.S. SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 12. Europe SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 13. JAPAN SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 14. CHINA SANGERS SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2017
FIGURE 15. INDIA SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 16. SOUTH-EAST ASIA SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 17. REST OF THE WORLD SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 18. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION
FIGURE 19. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, 2013 AND 2025 ($MILLION)
FIGURE 20. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, 2013 AND 2025 ($MILLION)
FIGURE 21. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, 2013 AND 2025 ($MILLION)
FIGURE 22. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, 2013 AND 2025 ($MILLION)
FIGURE 23. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR FORENSICS, 2013 AND 2025 ($MILLION)
FIGURE 24. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR OTHERS, 2013 AND 2025 ($MILLION)
FIGURE 25. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2013 AND 2025 ($MILLION)
FIGURE 26. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 27. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 28. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, 2013 AND 2025 ($MILLION)
FIGURE 29. GENSCRIPT: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 31. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)
FIGURE 32. LGC: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. SOURCE BIOSCIENCE: NET SALES, 2013-2015 ($MILLION)
FIGURE 34. SOURCE BIOSCIENCE: REVENUE SHARE BY DIVISION, 2015 ($MILLION)
FIGURE 35. THERMO FISHER: NET SALES, 2015-2017 ($MILLION)
FIGURE 36. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 37. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)
